{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Lee YJ"],"pubmed_abstract":["<h4>Introduction</h4>Breast cancer (BC) treatments can impair fertility in young women, causing considerable distress and potentially influencing treatment decisions, yet comprehensive real-world data on pregnancy outcomes after BC remain limited. This study aims to provide comprehensive real-world data on pregnancy following BC treatment to guide clinical practice and patient counseling.<h4>Methods</h4>We conducted a retrospective cohort study using medical records from a single tertiary medical center in South Korea. The study included 995 premenopausal women aged 18 to 40 years who were diagnosed with stage 0-III BC between December 2010 and September 2020. The primary outcomes included post-treatment pregnancy rates, factors associated with subsequent pregnancy, timing of conception, p"],"journal":["Frontiers in oncology"],"pagination":["1656429"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12414922"],"repository":["biostudies-literature"],"pubmed_title":["Pregnancy after breast cancer treatment in young patients."],"pmcid":["PMC12414922"],"pubmed_authors":["Yoo TK","Kim S","Son BH","Kim HJ","Lee YJ","Kim J","Chung IY","Lee SB","Ko BS","Lee JW"],"additional_accession":[]},"is_claimable":false,"name":"Pregnancy after breast cancer treatment in young patients.","description":"<h4>Introduction</h4>Breast cancer (BC) treatments can impair fertility in young women, causing considerable distress and potentially influencing treatment decisions, yet comprehensive real-world data on pregnancy outcomes after BC remain limited. This study aims to provide comprehensive real-world data on pregnancy following BC treatment to guide clinical practice and patient counseling.<h4>Methods</h4>We conducted a retrospective cohort study using medical records from a single tertiary medical center in South Korea. The study included 995 premenopausal women aged 18 to 40 years who were diagnosed with stage 0-III BC between December 2010 and September 2020. The primary outcomes included post-treatment pregnancy rates, factors associated with subsequent pregnancy, timing of conception, p","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-06-01T16:08:45.082Z","creation":"2026-04-08T14:04:04.408Z"},"accession":"S-EPMC12414922","cross_references":{"pubmed":["40927521"],"doi":["10.3389/fonc.2025.1656429"]}}